Reanalysis of the Multi‐Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic‐Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleischmann et al

Saved in:
Bibliographic Details
Published inArthritis & rheumatology (Hoboken, N.J.) Vol. 69; no. 4; pp. 863 - 865
Main Authors Curtis, Jeffrey R., Wright, Grace C., Strand, Vibeke, Davis, Charles S., Hitraya, Elena, Sasso, Eric H.
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.04.2017
John Wiley and Sons Inc
Subjects
Abatacept
Adalimumab
Antirheumatic Agents
Arthritis
Arthritis, Rheumatoid
Biological Products
Biomarkers
Humans
Immunotherapy
Letters
Methotrexate
Monoclonal antibodies
Rheumatoid arthritis
TNF inhibitors
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Correspondence-1
ObjectType-Commentary-2
content type line 23
The copyright line for this article was changed on 16 September 2019 after original online publication.
ISSN:2326-5191
2326-5205
2326-5205
DOI:10.1002/art.39981